Unichem Labs gets tentative nod for ANDA of sitagliptin tablets

Unichem Labs gets tentative nod for ANDA of sitagliptin tablets

by admin- Monday, July 12th, 2021 04:14:44 PM

Unichem Laboratories received Tentative Approval for ANDA of Sitagliptin Tablets USP, 25 mg, 50 mg, and a hundred mg from america Food and Drug Administration (USFDA) for a well-known version of Januvia (sitagliptin) pills, 25 mg, 50 mg, and one hundred mg, of Merck Sharpe and Dohme Corp (Merck).

Sitagliptin capsules are indicated as an accessory to food plan and workout to improve glycemic control in adults with kind 2 diabetes mellitus. Product may be commercialized from Unichem’s Goa Plant on receipt of complete approval.

News Updates